English
Home > Products > 912273-65-5

China 912273-65-5 Factory

We emphasize advancement and introduce new products and solutions into the market each year for 912273-65-5,CAS NO 912273-65-5,Edoxaban API,Edoxaban, We look ahead to receiving your enquires quickly and hope to have the chance to get the job done together with you inside the future. Welcome to get a seem at our organization.
912273-65-5, With the support of our highly experienced professionals, we manufacture and supply best quality items. These are quality tested at various occasions to ensure only flawless range is delivered to customers, we also customize the array as per the require of customers to meet the requirement of customers.

Related Products

Hot Products

  • Asarone

    Asarone

    Product Name:Asarone
    Molecular Formula:C16H25ClN4O4
    Molecular Weight;372.85
    CAS Registry Number;88465-81-0
  • Ketorolac tris salt

    Ketorolac tris salt

    Name:Ketorolac tris salt Synonyms:(+/-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid tris(hydroxymethyl)methylamine salt; Toradol Molecular Formula:C15H13NO3.C4H11NO3 Molecular Weight:376.40 CAS Registry Number:74103-07-4
  • 4-Hydroxy-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide

    4-Hydroxy-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide

    Product Name:4-Hydroxy-N,N,2-trimethyl-1-tosyl-1H-benzo[d]imidazole-6-carboxamide
    CAS number: 942195-86-0
    Molecular formula: C18H19N3O4S
  • 2-Bromo-6-(trifluoromethyl)pyridine

    2-Bromo-6-(trifluoromethyl)pyridine

    Product Name:2-Bromo-6-(trifluoromethyl)pyridine
    Molecular Formula:C6H3BrF3N
    Molecular Weight:225.99
    CAS Registry Number:189278-27-1
  • Lasmiditan succinate

    Lasmiditan succinate

    Product Name:Lasmiditan succinate
    Molecular Formula:C23H24F3N3O6
    Molecular Weight;495.46
    CAS Registry Number;439239-92-6
  • Benzyl hydroxy(4-phenylbutyl)phosphinoylacetate

    Benzyl hydroxy(4-phenylbutyl)phosphinoylacetate

    Product Name:Benzyl hydroxy(4-phenylbutyl)phosphinoylacetate
    Molecular Formula:C19H23O4P
    Molecular Weight:346.36
    CAS Registry Number:87460-09-1
  • Related Blog
  • Reviews

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Related Search

CAS NO 912273-65-5

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept